Answers are grounded in this paper and cite their sources.
Background: Stimuli-responsive hydrogels based on poly(N-isopropylacrylamide) (p(NIPAM)) have emerged as promising candidates for advanced biomedical applications, including biosensing, drug delivery, tissue engineering, and wound healing due to their unique thermosensitivity. The mini-emulsion approach enables engineering of p(NIPAM) microgels with a tunable particle size, architecture, and physicochemical properties. Methods: In this study, we synthesized soft, ultra-low-cross-linked microgels based on p(NIPAM) copolymers with methacrylic acid and methacrylate-terminated polyethylene glycol. Results: The obtained microgels exhibited a sharp volume phase transition within the narrow temperature range of 32–36 °C, accompanied by a 100-fold increase in the particle’s stiffness (Young’s modulus), which corresponded to the copolymer’s lower critical solution temperature (LCST). For the first time, we systematically investigated the dynamics of cellular internalization of these microgels using immortalized human keratinocytes (HaCaT), including 2D monolayers and 3D spheroid models to better mimic skin architecture. Our results revealed significantly enhanced microgel internalization at 37 °C compared to 25 °C, coinciding with temperature-induced changes in particle size and mechanical properties. Furthermore, the immunomodulatory potential of the developed carriers was evaluated using human monocyte-derived macrophages. Notably, the microgels were phagocytosed by macrophages and promoted pro-inflammatory activity in immune cells, modulating the secretion of key cytokines (IL-6, TNF-α) and influencing the cellular responses relevant to early wound-healing stages. Conclusions: These findings demonstrate that the created p(NIPAM)-based microgels possess a favorable combination of stimuli-responsiveness, efficient cellular uptake, and immunomodulatory activity. The obtained findings provide a basis for further investigation of p(NIPAM)-based microgels as potential stimuli-responsive carriers for cutaneous drug delivery, smart wound dressings, and regenerative medicine applications, although their therapeutic efficacy remains to be established.
No takes yet. Share an insight, caveat, or question.
Nifontova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: